BIOA vs CBOE · rev $9.0M vs P/E 24, rev $2.72B
BioAge Labs, Inc (BIOA) versus Cboe Global Markets Inc (CBOE) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
BIOA currently screens at market cap $697.9M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Not investment advice. Open the BIOA and CBOE stock pages for the full models.
Not investment advice.